Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.VIRUSRES.2010.10.021 | ||||
| Año | 2011 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The infectious salmon anemia virus (ISAV) is the causative agent of the ISA syndrome that affects mainly Atlantic salmon (Salmo solar) and has caused high mortality epidemics in Norway, Scotland, Canada, the United States and Chile. It is classified as an Orthomyxoviridae, its genome is composed of 8 single-strand RNA segments with negative polarity that code for 11 polypeptides. Through functional studies of the coded proteins it has been established that RNA segments 5 and 6 code for a fusion protein and hemagglutinin, respectively, while two polypeptides coded by segments 7 and 8 inhibit interferon induction. The functions of the rest of the possible proteins coded by the viral genome have been assigned by comparison with the corresponding ones of the influenza virus genome. As to its pathogenicity, some growth parameters such as incubation period, resistance to chemical and physical factors, establishment of the infection in other marine species, and dissemination ability among the different organs have been evaluated in several salmonids. Genomic analysis has shown (i) the existence of a high polymorphism region (HPR) in segment 6, and (ii) sequence insertion in segment 5. More than 20 HPR variants have been determined, all originating from HPR0, which is associated with low pathogenicity, while 4 different sequence insertions in segment 5 have not been related with some characteristic of the virus infection. Much progress has been made in the characterization of the virus in 20 years of study, but more detailed knowledge of the specific function of the proteins coded by all the viral genes is still missing, including the pathogenicity mechanism at the molecular level. (C) 2010 Elsevier B.V. All rights reserved.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | COTTET-BUSTAMANTE, LUIS EDUARDO | Hombre |
Universidad de Santiago de Chile - Chile
|
| 2 | Rivas-Aravena, Andrea | Mujer |
Labs GAM SA - Chile
Laboratorios GAM S.A. - Chile |
| 3 | Cortez-San-Martin, Marcelo | Hombre |
Universidad de Santiago de Chile - Chile
|
| 4 | SANDINO-GARCIA, ANA MARIA | Mujer |
Universidad de Santiago de Chile - Chile
Labs GAM SA - Chile Laboratorios GAM S.A. - Chile |
| 5 | SPENCER-OSSA, EUGENIO GERMAN | Hombre |
Universidad de Santiago de Chile - Chile
|
| Fuente |
|---|
| CONICYT |
| INNOVA-CORFO |
| Comisión Nacional de Investigación Científica y Tecnológica |
| Comisión Nacional de Investigación CientÃfica y Tecnológica |
| PBCT-CONICYT |
| Agradecimiento |
|---|
| This study was supported by Innova-CORFO grants: 09MCSS-6691, 09MCSS-6698 and 07CN13PBT-90 (Government of Chile). M.C. was supported by PBCT-CONICYT grant PDA-20 (Government of Chile). L.C. was supported by a fellowship from CONICYT (Government of Chile) and belongs to the Doctorate in Biotechnology Program, USACH. Samy Atala by help us with the translation and editing of the English text. |
| This study was supported by Innova-CORFO grants: 09MCSS-6691 , 09MCSS-6698 and 07CN13PBT-90 (Government of Chile). M.C. was supported by PBCT-CONICYT grant PDA-20 (Government of Chile). L.C. was supported by a fellowship from CONICYT (Government of Chile) and belongs to the Doctorate in Biotechnology Program, USACH. Samy Atala by help us with the translation and editing of the English text. |